General Information


DRAVP ID  DRAVPe01346

Peptide Name   hEP-9

Sequence  VRLASHLRKLRKRLLRDADDLQKRLAVY

Sequence Length  28

UniProt ID  P02649 

Source  Synthetic construct(derived from human apolipoprotein E)



Activity Information


Target Organism  HCV

Assay  RT PCR

Activity 

  • [Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  Not found

Mechanism  hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe01346

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C150H264N52O38

Absent amino acids  CEFGIMNPTW

Common amino acids  L

Mass  3404.07

Pl  11.38

Basic residues  10

Acidic residues  3

Hydrophobic residues  12

Net charge  7

Boman Index  -9812

Hydrophobicity  -62.86

Aliphatic Index  128.93

Half Life 

  •     Mammalian:100 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  55.19

Polar residues  2



Literature Information


Literature 1

Title   Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Pubmed ID   22334503

Reference   Hepatology. 2012 Aug;56(2):484-91.

Author   Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.

DOI   10.1002/hep.25665